SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
4.020
+0.070 (1.77%)
At close: Nov 24, 2025, 4:00 PM EST
3.940
-0.080 (-1.99%)
After-hours: Nov 24, 2025, 6:05 PM EST
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $191.38 million as of November 24, 2025. Its market cap has increased by 534.13% in one year.
Market Cap
191.38M
Enterprise Value
86.69M
1-Year Change
534.13%
Ranking
Category
Stock Price
$4.02
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $191.38M, an increase of 46.37%. That is a compound annual growth rate of 8.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 191.38M | 446.52% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | 130.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |